Screener
Rhythm Pharmaceuticals, Inc. RYTM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts receivable, net | 34,192 | 26,081 |
| Inventory | 28,651 | 25,753 |
| Prepaid expenses and other current assets | 26,622 | 26,133 |
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s total current assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total current assets of $430.09M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total current assets increased by 16.5% year-over-year, from $369.29M to $430.09M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s total current assets has grown at a 20.8% compound annual growth rate (CAGR), from $181.67M to $466.92M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude